108 related articles for article (PubMed ID: 7794535)
1. Preparation and characteristics of magnetite-labelled antibody with the use of poly(ethylene glycol) derivatives.
Suzuki M; Shinkai M; Kamihira M; Kobayashi T
Biotechnol Appl Biochem; 1995 Jun; 21(3):335-45. PubMed ID: 7794535
[TBL] [Abstract][Full Text] [Related]
2. Preparation of ferrimagnetic magnetite microspheres for in situ hyperthermic treatment of cancer.
Kawashita M; Tanaka M; Kokubo T; Inoue Y; Yao T; Hamada S; Shinjo T
Biomaterials; 2005 May; 26(15):2231-8. PubMed ID: 15585224
[TBL] [Abstract][Full Text] [Related]
3. Heat-Generating Iron Oxide Multigranule Nanoclusters for Enhancing Hyperthermic Efficacy in Tumor Treatment.
Jeon S; Park BC; Lim S; Yoon HY; Jeon YS; Kim BS; Kim YK; Kim K
ACS Appl Mater Interfaces; 2020 Jul; 12(30):33483-33491. PubMed ID: 32614594
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of temperature increase with different amounts of magnetite in liver tissue samples.
Hilger I; Andrä W; Bähring R; Daum A; Hergt R; Kaiser WA
Invest Radiol; 1997 Nov; 32(11):705-12. PubMed ID: 9387059
[TBL] [Abstract][Full Text] [Related]
5. A multi-controlled drug delivery system based on magnetic mesoporous Fe
Zhang Q; Liu J; Yuan K; Zhang Z; Zhang X; Fang X
Nanotechnology; 2017 Oct; 28(40):405101. PubMed ID: 28837053
[TBL] [Abstract][Full Text] [Related]
6. Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia.
Shinkai M; Suzuki M; Iijima S; Kobayashi T
Biotechnol Appl Biochem; 1995 Apr; 21(2):125-37. PubMed ID: 7718156
[TBL] [Abstract][Full Text] [Related]
7. [A method of showing thermal effect of iron oxide nanoparticles in alternating magnetic field].
Liu X; Xu B; Xia QS; Zhao TD; Tang JT
Ai Zheng; 2005 Sep; 24(9):1148-50. PubMed ID: 16159444
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic preparation of hollow magnetite microspheres for hyperthermic treatment of cancer.
Kawashita M; Sadaoka K; Kokubo T; Saito T; Takano M; Araki N; Hiraoka M
J Mater Sci Mater Med; 2006 Jul; 17(7):605-10. PubMed ID: 16770544
[TBL] [Abstract][Full Text] [Related]
9. Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles.
Suzuki M; Honda H; Kobayashi T; Wakabayashi T; Yoshida J; Takahashi M
Noshuyo Byori; 1996 Nov; 13(2):127-32. PubMed ID: 8958518
[TBL] [Abstract][Full Text] [Related]
10. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.
Shinkai M; Yanase M; Honda H; Wakabayashi T; Yoshida J; Kobayashi T
Jpn J Cancer Res; 1996 Nov; 87(11):1179-83. PubMed ID: 9045948
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of PEG-iron oxide core-shell composite nanoparticles for thermal therapy.
Wydra RJ; Kruse AM; Bae Y; Anderson KW; Hilt JZ
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4660-6. PubMed ID: 24094173
[TBL] [Abstract][Full Text] [Related]
12. New ferromagnetic bone cement for local hyperthermia.
Takegami K; Sano T; Wakabayashi H; Sonoda J; Yamazaki T; Morita S; Shibuya T; Uchida A
J Biomed Mater Res; 1998; 43(2):210-4. PubMed ID: 9619440
[TBL] [Abstract][Full Text] [Related]
13. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia.
Ito A; Kuga Y; Honda H; Kikkawa H; Horiuchi A; Watanabe Y; Kobayashi T
Cancer Lett; 2004 Aug; 212(2):167-75. PubMed ID: 15279897
[TBL] [Abstract][Full Text] [Related]
14. Electromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice.
Hilger I; Andrä W; Hergt R; Hiergeist R; Schubert H; Kaiser WA
Radiology; 2001 Feb; 218(2):570-5. PubMed ID: 11161180
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors.
Cerdan S; Lötscher HR; Künnecke B; Seelig J
Magn Reson Med; 1989 Nov; 12(2):151-63. PubMed ID: 2615625
[TBL] [Abstract][Full Text] [Related]
16. Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors.
Mitsumori M; Hiraoka M; Shibata T; Okuno Y; Nagata Y; Nishimura Y; Abe M; Hasegawa M; Nagae H; Ebisawa Y
Hepatogastroenterology; 1996; 43(12):1431-7. PubMed ID: 8975944
[TBL] [Abstract][Full Text] [Related]
17. High salt stability and protein resistance of poly(L-lysine)-g-poly(ethylene glycol) copolymers covalently immobilized via aldehyde plasma polymer interlayers on inorganic and polymeric substrates.
Blättler TM; Pasche S; Textor M; Griesser HJ
Langmuir; 2006 Jun; 22(13):5760-9. PubMed ID: 16768506
[TBL] [Abstract][Full Text] [Related]
18. Preparation of PEG-grafted immunomagnetoliposomes entrapping citrate stabilized magnetite particles and their application in CD34+ cell sorting.
Domingo JC; Mercadal M; Petriz J; De Madariaga MA
J Microencapsul; 2001; 18(1):41-54. PubMed ID: 11201340
[TBL] [Abstract][Full Text] [Related]
19. Characterization of PEG-iron oxide hydrogel nanocomposites for dual hyperthermia and paclitaxel delivery.
Meenach SA; Shapiro JM; Hilt JZ; Anderson KW
J Biomater Sci Polym Ed; 2013; 24(9):1112-26. PubMed ID: 23683041
[TBL] [Abstract][Full Text] [Related]
20. LyP-1-conjugated Fe
Teo P; Wang X; Zhang J; Zhang H; Yang X; Huang Y; Tang J
J Biomater Sci Polym Ed; 2018 Feb; 29(2):181-194. PubMed ID: 29165044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
